Qiang Wu

机构：Sichuan University, West China Hospital of Sichuan University, Guangzhou Women and Children Medical Center, Sichuan Cancer Hospital, Yibin University, Guangzhou Medical University · ORCID：0000-0002-5425-815X

发表论文 33 篇 · 总被引 632 次 · h-index 12

代表论文

• Cyclooxygenase-2 Inhibitor: A Potential Combination Strategy With Immunotherapy in Cancer (2021 · Frontiers in Oncology · 被引 100)
• Automatic delineation of the clinical target volume and organs at risk by deep learning for rectal cancer postoperative radiotherapy (2020 · Radiotherapy and Oncology · 被引 78)
• Prognostic Value of Ki-67 in Patients With Resected Triple-Negative Breast Cancer: A Meta-Analysis (2019 · Frontiers in Oncology · 被引 74)
• Controlling Nutritional Status (CONUT) score is a prognostic factor in patients with resected breast cancer (2020 · Scientific Reports · 被引 56)
• First-Generation EGFR-TKI Plus Chemotherapy Versus EGFR-TKI Alone as First-Line Treatment in Advanced NSCLC With EGFR Activating Mutation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2021 · Frontiers in Oncology · 被引 39)
• Systemic Immune-Inflammation Index Is a Prognostic Factor for Breast Cancer Patients After Curative Resection (2021 · Frontiers in Oncology · 被引 38)